Patient Intelligence Platform for Genetic Disease
Patients with rare and complex genetic diseases are often undiagnosed or hard to find and connect to appropriate diagnoses, clinical trials, and treatments, slowing drug development and access to care.
A patient intelligence data platform that identifies undiagnosed patients online, analyzes disease state with machine learning and at-home testing, and enables compliant communication to connect patients with diagnoses, trials, and therapies.
Drug developers and patient advocacy groups use the platform to find and engage genetic disease patients and support treatment development and launch.
CEO & Co-Founder of Probably Genetic. Previously BCG & The Bill & Melinda Gates Foundation. PhD from Oxford as a Rhodes Scholar.




